Drug Shortage Report for RIVA-LETROZOLE
Report ID | 216506 |
Drug Identification Number | 02398656 |
Brand name | RIVA-LETROZOLE |
Common or Proper name | Riva-Letrozole |
Company Name | LABORATOIRE RIVA INC. |
Market Status | MARKETED |
Active Ingredient(s) | LETROZOLE |
Strength(s) | 2.5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 30 |
ATC code | L02BG |
ATC description | HORMONE ANTAGONISTS AND RELATED AGENTS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | 2024-01-18 |
Actual start date | 2024-01-18 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-01-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 660 BOUL. INDUSTRIEL BLAINVILLE, QUEBEC CANADA J7C 3V4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2024-01-19 | English | Compare |
v2 | 2024-01-18 | French | Compare |
v1 | 2024-01-18 | English | Compare |
Showing 1 to 3 of 3